All Articles

White River Bancshares' minor correction to its dividend date reveals a major truth: in the world of finance, precision is not just a detail, it's the product.

Health Canada's approval of a generic Wegovy promises to slash costs and expand access, shifting the landscape for patients and the healthcare system.

Vishay seeks a massive capital infusion to fund innovation and slash debt. We unpack the strategy, the market's nervous reaction, and what it means for the sector.

Dr. Julie Brown just won an award previously given to tech giants like Gordon Moore. Her quiet, decades-long work on OLEDs is why your phone screen pops.

Live Oak Bank's hire of a top accounting chief isn't just a personnel move. It signals a new age of accountability for digital banks, where growth meets governance.

DHT Holdings is retrofitting brand-new tankers, a bold move showcasing how operational foresight and tech upgrades are key to navigating today's complex shipping market.

As Solar & Storage Live Vietnam marks its 10th year, it's more than an expo; it's the operational heart of a nation's ambitious $135 billion energy revolution.

Norwegian Cruise Line hires luxury brand guru Lee Applbaum to navigate its massive expansion. Can a playbook from premium tequila and private jets redefine cruise marketing?

Pathfinder Bancorp's latest dividend signals stability. But beneath the surface, it reveals a story of regional resilience and careful navigation of financial headwinds.

A new chemo-free combo from Genmab and AbbVie shows a 60% reduction in disease progression for a tough-to-treat blood cancer, setting a new standard.

AeroVironment posts a 141% revenue jump after major acquisitions, but a $265M net loss and accounting issues reveal the high cost of its ambitious growth.

Curbline Properties is raising a war chest via a complex stock offering. We decode the forward sale, its impact on shareholders, and why it's a signal of aggressive expansion.

Blackstone's $2.3B stock sale in Digital Realty post-acquisition raises questions. Is this a strategic cash-out or a vote of confidence in the data center giant?

With FDA clearance, Gain Therapeutics' GT-02287, an AI-discovered drug, advances to Phase 2, offering a new hope to modify Parkinson's, not just its symptoms.

The energy giant is redeeming preferred units. It's not just housekeeping—it’s a calculated move reflecting deep financial health and a sector-wide shift.

Frontdoor adds homebuilder CFO Hilla Sferruzza to its board. It's more than a new seat—it's a strategic move to master the housing lifecycle.

Beyond the hype of new cosmetic lasers lies an invisible digital infrastructure of 'edvertising' and data, shaping how we manage aging and choose our care.

Saskatchewan's new law swaps courtrooms for curbside penalties, a move hailed as a breakthrough for road safety but one that fundamentally alters justice.

Anta Group’s founding family is investing billions in public health. It’s not just charity; it’s a masterclass in strategic legacy-building.

In a world of digital noise, brands are rediscovering a powerful tool: the physical PR box. Explore the strategic return to tangible marketing.